A quiet crisis is unfolding within the world of medical testing, particularly in the rapidly expanding field of genetic diagnostics. The Centers for Medicare & Medicaid Services (CMS) recently launched an initiative – CRUSH – to address a deeply rooted problem: fraud, waste, and abuse that threatens to undermine the promise of precision medicine.
